Showing results (1491-1500 of 1,886) with videos related to

Sort By:
Pageof 189
The Review of Scientific Instruments|September 22, 2023
Full aperture backscatter diagnostics for characterization of laser plasma instabilities at the extreme light infrastructure (ELI) beamlinesF Wasser, Ş Zähter, M Sokol, et al.
The American Journal of Pathology|February 2, 2011
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesMitchell J Frederick, Amy J VanMeter, Mayur A Gadhikar, et al.
Oral Oncology|June 28, 2005
Elective and therapeutic selective neck dissectionAlfio Ferlito, Alessandra Rinaldo, Carl E Silver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With PembrolizumabF Stephen Hodi, Wen-Jen Hwu, Richard Kefford, et al.
Head & Neck|February 1, 2021
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neckSamantha Tam, Mona Gajera, Xiaoning Luo, et al.
Head & Neck|April 13, 2011
Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapyIvan Marcelo Gonçalves Agra, Alfio Ferlito, Robert P Takes, et al.
The Lancet. Oncology|February 7, 2017
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trialCorneel Coens, Stefan Suciu, Vanna Chiarion-Sileni, et al.
Nature|December 9, 2021
Non-genetic determinants of malignant clonal fitness at single-cell resolutionKatie A Fennell, Dane Vassiliadis, Enid Y N Lam, et al.
Annals of Surgical Oncology|December 29, 2022
Impact of Cancer Care Regionalization on Patient VolumeKevin J Contrera, Samantha Tam, Kristen Pytynia, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Pageof 189